Screening for glioma

At present, screening for gliomas has no clinical relevance. This is because of the low incidence, the lack of sensitive biomarkers in plasma, and the observation that gliomas may develop apparently de novo within few weeks or months. To the best of our knowledge, there is no routine use of a serum biomarker for clinical follow-up 1).

Linhares P, Carvalho B, Vaz R, Costa BM. Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance? Int J Mol Sci. 2020 Aug 13;21(16):5809. doi: 10.3390/ijms21165809. PMID: 32823572; PMCID: PMC7461098.
  • screening_for_glioma.txt
  • Last modified: 2021/03/01 13:50
  • by